amfAR, The Foundation for AIDS Research

Community Advocacy and Policy

TREAT Asia plays a key advocacy role in the region, using data gathered through the network and its research, to make the case for evidence-based HIV-related policy and programming. TREAT Asia works closely with individual country-based and regional advocates, and amfAR’s U.S.-based Public Policy Office and Public Information department to develop strategies for urging governments, HIV/AIDS organizations, donors, and pharmaceutical companies to invest in broader access to affordable, high-quality HIV and co-infection treatment, and for the removal of barriers that prevent many people, including key-affected populations, from accessing care.

These barriers may include high pricing of medicines, low awareness of infection and advocacy opportunities among patient groups, national drug regulatory delays, trade negotiations, and non-availability of highly potent medications in national programs.

protest 
Indonesian protestors demand access to affordable sofosbuvir, 2015

TREAT Asia also supports national and regional programs working to build skills and empower those at risk, infected, or affected by HIV/AIDS. For example, through its Youth Asia Community for AIDS Treatment and Advocacy (ACATA) program, it helps young people who have grown up with HIV develop leadership skills, understand their infection and their rights, and advocate at the national, regional, or international level.
   

HIV AWARENESS, prevention and diagnosis


HIV in Southeast Asia: Progress, Process, and the Work Ahead
Vigilance Needed to Sustain Global Fight Against HIV
Adam’s Love Launches a New Clinic for GMT Individuals in Bangkok
Online HIV Awareness Campaign Debuts in Malaysia 

 

HIV and co-infection treatment access


When Drugs Cost as Much as Diamonds
TREAT Asia Pushes for Expanded Access to Hepatitis C Treatments
Fact Sheet on WHO Guidelines for the Screening, Care, and Treatment of Persons with Hepatitis C Infection
CoNE, India, Is Selected in Global Hepatitis Innovation Testing Contest
Addressing the Challenges to HIV/Hepatitis C Treatment Access – The TREAT Asia Report Interview: Leena Menghaney of MSF
Hepatitis C Treatment Snapshots: Ledipasvir + Sofosbuvir
Hepatitis C Treatment Snapshots: Daclatasvir
How Activists Are Driving Down the Cost of Hepatitis C Treatment in Asia
Hepatitis C Treatment Snapshots: Sofosbuvir
Hepatitis C and Drug Pricing: The Need for a Better Balance
Policy Brief: Hepatitis C and HIV – Addressing the Dual Epidemic
HIV Treatment Snapshot: Dolutegravir
The High Cost of Free Trade for People Living with HIV in the Asia-Pacific 

 

HIV and noninfectious comorbidities


Addressing Unmet Needs Associated With Cardiovascular Disease in People With HIV/AIDS 

 

Youth advocacy and leadership


Young People With HIV Finding Their Voice
TREAT Asia’s New Program to Help Build Regional Youth HIV Advocacy Capacity 

 

Adolescent, Child, and orphan care


New Initiative Addresses Adolescent Mental Health
Helping Young People Transition to Adult Care
New Hope for Cambodian Children 

 

PRE-EXPOSURE PROPHYLAXIS (PrEP)


PrEP Acceptability Among Female Sex Workers in Thailand: Key Research Findings
Creating Access to PrEP in the Philippines
Expanding Pre-Exposure Prophylaxis (PrEP) for HIV in Thailand 

 

Sexual and reproductive health


Cervical Cancer in Asia: A Deadly but Preventable Epidemic
Improving Reproductive Health in Young Thai Women
Policy Brief: Sexual and Reproductive Health of HIV-Positive Women in Asia 

 

Stigma and discrimination

 
Fighting HIV Among MSM and Transgender Individuals in Myanmar
New Videos Combating HIV Stigma Are Broadcast Across Thailand
Be the Change This International Day Against Homophobia and Transphobia
Taking Discrimination to Court in India


Community Mobilization


A Mission to Mobilize HIV Communities Worldwide